Journal
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Volume 20, Issue 6, Pages 525-530Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PAI.0b013e318251d8c1
Keywords
immunohistochemistry; lung carcinoma; thyroid transcription factor-1; squamous cell carcinoma
Ask authors/readers for more resources
Thyroid transcription factor-1 (TTF-1) is one of the peripheral airway epithelial markers that, because it is commonly expressed in lung adenocarcinomas, but not in squamous cell carcinomas, is regarded as being useful in distinguishing between these 2 malignancies, especially in those instances in which the diagnosis cannot be made on routine histology. Even though it is generally believed that TTF-1 is not expressed in squamous cell carcinomas of the lung, a significant number of studies have reported positivity for this marker in up to 38% of the cases investigated. To determine the causes of these discrepancies, 85 pulmonary and 50 nonpulmonary squamous cell carcinomas (17 skin, 8 esophagus, 5 uterine cervix, and 20 from the head-and-neck region) were investigated by immunohistochemistry for TTF-1. None of the 85 squamous cell carcinomas of the lung showed reactivity in the neoplastic cells; however, because strong TTF-1 positivity was observed in the hyperplastic type II pneumocytes that were sometimes seen entrapped within the tumor, it is concluded that the presence of these entrapped cells was one of the most likely causes of the discrepancies. In addition, after a careful review of all of the previous publications on TTF-1 expression in squamous cell carcinomas of the lung, it was found that other factors, such as the type of antibody used and the selection of the cases, may have been the cause of the discrepancies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available